On the 18th, CCTV News reported that the China Institute of Atomic Energy, a subsidiary of the China National Nuclear Corporation (CNNC), has successfully developed China's first 10MeV ultra-compact medical cyclotron, achieving beam extraction with all key indicators meeting the required standards. This cyclotron is capable of producing a variety of short-lived medical isotopes, including fluorine-18, gallium-68, and carbon-11. It offers several advantages, such as a compact size, cost-effectiveness, and ease of maintenance, making it a crucial piece of equipment in line with the national strategy of establishing nuclear medicine departments in "one county, one clinic". It can cater to the need for "on-site production and immediate use" of short-lived isotope drugs, offering substantial technical support for the miniaturization and practical application of medical cyclotrons. Traditional medical isotope production equipment has hindered the widespread adoption of nuclear medicine technology due to its large size and high costs. The research team at the China Institute of Atomic Energy has overcome several key technological challenges, enabling the main unit of the new cyclotron to occupy a mere 1.4 meters × 1.4 meters, significantly broadening the device's range of applications. Additionally, the team has also acquired technologies for producing targets of various isotopes, endowing the device with "multi-functionality" to flexibly produce multiple commonly used isotopes.